Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once‐a‐week versus once‐every‐3‐weeks cisplatin

INTRODUCTION: This trial was conducted to compare the efficacy of low dose once‐a‐week cisplatin and once‐every‐3‐weeks cisplatin with radiation in locally advanced head and neck squamous cell carcinoma (LAHNSCC). The current analysis focuses on the quality of life (QoL) of patients in this trial. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Nandini S., Noronha, Vanita, Patil, Vijay Maruti, Joshi, Amit, Bhattacharjee, Atanu, Kalra, Devanshi, Laskar, Sarbani Ghosh, Mathrudev, Vijayalakshmi, Nawale, Kavita, Bhelekar, Arati S., Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636500/
https://www.ncbi.nlm.nih.gov/pubmed/35343648
http://dx.doi.org/10.1002/cam4.4715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636500/
https://www.ncbi.nlm.nih.gov/pubmed/35343648
http://dx.doi.org/10.1002/cam4.4715

Ejemplares similares